Sobanski Esther, Schredl Michael, Kettler Nina, Alm Barbara
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany.
Sleep. 2008 Mar;31(3):375-81. doi: 10.1093/sleep/31.3.375.
Sleep problems are frequently associated with childhood ADHD, as indicated by numerous polysomnographic investigations showing increased nocturnal movements, reduced sleep efficiency, and decreased percentage of REM sleep (although findings are not consistent over all studies). Data on objective and subjective sleep parameters in adults with ADHD are sparse, and to date the impact of stimulants, the most widely used pharmacological treatment for ADHD, on sleep in adults with ADHD has not been examined. Thus the objectives of our study were to assess objective and subjective sleep parameters in adults with ADHD and the impact of stimulant medication on sleep.
Two-group comparison and open-label therapy study.
We enrolled 34 nonmedicated patients with ADHD, of whom 24 were without current comorbid psychiatric disorders, and 34 sex- and gender-matched control subjects without current psychiatric disorders or psychotropic medication.
Ten patients were treated with methylphenidate over > or =26 days with a mean daily dose of 36.7 +/- 11.2 mg.
Polysomnographic recording over 2 consecutive nights as well as assessments of subjective sleep parameters were performed in all patients and controls before treatment and reassessed in those patients receiving methylphenidate.
Compared to controls untreated patients showed increased nocturnal activity, reduced sleep efficiency, more nocturnal awakenings and reduced percentage of REM sleep. Treatment with methylphenidate resulted in increased sleep efficiency as well as a subjective feeling of improved restorative value of sleep.
Sleep problems in patients with ADHD continue from childhood to adulthood, with similar objective sleep characteristics in adults and children with ADHD. Medication with methylphenidate appears to have beneficial effects on sleep parameters in adults with ADHD.
睡眠问题常与儿童多动症相关,大量多导睡眠图研究表明,多动症患儿夜间活动增加、睡眠效率降低、快速眼动睡眠百分比下降(尽管并非所有研究结果都一致)。关于多动症成人患者客观和主观睡眠参数的数据较少,迄今为止,治疗多动症最常用的药物兴奋剂对多动症成人患者睡眠的影响尚未得到研究。因此,我们研究的目的是评估多动症成人患者的客观和主观睡眠参数以及兴奋剂药物对睡眠的影响。
两组比较和开放标签治疗研究。
我们招募了34名未接受药物治疗的多动症患者,其中24名目前没有共病精神障碍,以及34名性别和年龄匹配的对照受试者,他们目前没有精神障碍或正在服用精神药物。
10名患者接受哌甲酯治疗超过或等于26天,平均每日剂量为36.7±11.2毫克。
所有患者和对照在治疗前进行连续两晚的多导睡眠图记录以及主观睡眠参数评估,并对接受哌甲酯治疗的患者进行重新评估。
与对照组相比,未治疗的患者夜间活动增加、睡眠效率降低、夜间觉醒次数增多、快速眼动睡眠百分比降低。哌甲酯治疗可提高睡眠效率,并使患者主观感觉睡眠的恢复价值有所改善。
多动症患者的睡眠问题从儿童期持续到成年期,多动症成人和儿童具有相似的客观睡眠特征。哌甲酯药物治疗似乎对多动症成人患者的睡眠参数有有益影响。